UNSPSC 51263313: Tribendilol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K0744Q5ALP. European Medicines Agency schedules Tribendilol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11259MIG. Tribendilol generally arises in the molecular formula C18H22N4O4.

UNSPSC 51263313 Tribendilol, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The single recent opportunity on record—Seminole County, Florida's IFB 60459723LAS—solicits Naloxone and Safe Drug Deactivation Systems for community health support, a pharmaceutical and harm-reduction product category unrelated to Tribendilol, a beta-blocking cardiovascular agent. The mismatch suggests either a coding error in the source database or that Tribendilol procurement through state and local channels does not generate sufficient volume to populate this code's opportunity stream. No other recent opportunities appear in the dataset.

Seminole County's bid, posted June 30, 2026 with a response deadline of July 26, 2023 (a retroactive date suggesting data lag or correction in the source), requires annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with a one-year renewal option, E-Verify compliance, drug-free workplace certification, and standard insurance requirements. The county indicates potential FEMA funding, which imposes federal environmental compliance obligations. Without a second recent opportunity or corroborating activity under this Commodity code, practitioners evaluating Tribendilol procurement should treat the code as inactive for state and local business development purposes and rely instead on broader pharmaceutical or medical-supply family codes.